首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   199328篇
  免费   17979篇
  国内免费   7060篇
耳鼻咽喉   1301篇
儿科学   2868篇
妇产科学   2355篇
基础医学   9991篇
口腔科学   3650篇
临床医学   22553篇
内科学   23442篇
皮肤病学   2981篇
神经病学   7827篇
特种医学   5530篇
外国民族医学   44篇
外科学   15595篇
综合类   36964篇
现状与发展   35篇
一般理论   25篇
预防医学   11029篇
眼科学   2523篇
药学   18892篇
  377篇
中国医学   37369篇
肿瘤学   19016篇
  2024年   974篇
  2023年   3973篇
  2022年   7068篇
  2021年   9412篇
  2020年   9200篇
  2019年   7264篇
  2018年   6726篇
  2017年   7900篇
  2016年   8189篇
  2015年   7882篇
  2014年   15797篇
  2013年   17219篇
  2012年   13508篇
  2011年   14270篇
  2010年   11671篇
  2009年   10112篇
  2008年   9271篇
  2007年   9941篇
  2006年   8544篇
  2005年   7426篇
  2004年   5992篇
  2003年   5279篇
  2002年   4318篇
  2001年   3786篇
  2000年   3165篇
  1999年   2429篇
  1998年   1960篇
  1997年   1689篇
  1996年   1403篇
  1995年   1223篇
  1994年   987篇
  1993年   723篇
  1992年   686篇
  1991年   623篇
  1990年   502篇
  1989年   428篇
  1988年   411篇
  1987年   351篇
  1986年   273篇
  1985年   319篇
  1984年   281篇
  1983年   191篇
  1982年   198篇
  1981年   196篇
  1980年   164篇
  1979年   138篇
  1978年   73篇
  1977年   55篇
  1976年   57篇
  1975年   39篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
《Urologic oncology》2015,33(5):217-225
Although both surgery and radiation are potential curative options for men with clinically localized prostate cancer, a significant proportion of men with high-risk and locally advanced disease will demonstrate biochemical and potentially clinical progression of their disease. Neoadjuvant systemic therapy before radical prostatectomy (RP) is a logical strategy to improve treatment outcomes for men with clinically localized high-risk prostate cancer. Furthermore, delivery of chemotherapy and other systemic agents before RP affords an opportunity to explore the efficacy of these agents with pathologic end points.Neoadjuvant chemotherapy, primarily with docetaxel (with or without androgen deprivation therapy), has demonstrated feasibility and safety in men undergoing RP, but no study to date has established the efficacy of neoadjuvant chemotherapy or neoadjuvant chemohormonal therapies. Other novel agents, such as those targeting the vascular endothelial growth factor receptor, epidermal growth factor receptor, platelet-derived growth factor receptor, clusterin, and immunomodulatory therapeutics, are currently under investigation.  相似文献   
15.
16.
目的探讨脂肪抽吸与腹壁成形术联合进行腹壁体形重塑的临床疗效,总结手术成功与减少并发症的经验。方法对18例腹部脂肪堆积伴腹壁皮肤松弛的患者采用肿胀麻醉,负压吸引器行腹壁脂肪抽吸;做耻骨联合上W形切口,折叠缝合腹直肌前鞘,切除多余皮瓣后分层缝合腹壁。结果所有切口均Ⅰ期愈合,随访4~24个月,腹部平坦,切口瘢痕不明显,腹围平均缩小15 cm,外形满意。结论根据患者腹部皮肤、皮下脂肪、腹壁肌肉等多方面的情况,有针对性的采用脂肪抽吸与腹壁整形相结合的腹壁体形重塑术,能够获得满意的效果,手术方法安全可靠。  相似文献   
17.
18.
19.
The purpose of this literature review is to investigate clinical treatment methods of total body irradiation within the context of a clinical department adopting a paediatric cohort with no existing technique. An extensive review of the literature was conducted using PubMed, Science Direct, Google Scholar, and Clinicians Knowledge Network. Articles were limited to nonhelical tomotherapy, nonparticle therapies, and those using hyperfractionated regimes. Total marrow irradiation was excluded because of national treatment and trial limitations. Of the numerous patient positioning methods present within the literature, the most comfortable and reproducible positioning methods for total body irradiation include both supine and the supine and/or prone combination. These positions increased stability and patient comfort during treatment, while also facilitating computed tomography data acquisition at the simulation stage. Ideally, dose calculations should be performed using a three-dimensional treatment planning system and quality assurance procedures that include in vivo dosimetry measurements. The available literature also suggests inhomogeneity correction factors and intensity modulation are superior to conventional open field techniques and should be implemented within developing protocols. Dynamic machine dose modulation is suggested to reduce department impact, removing the need for tissue compensators and accessory shielding devices, while providing significant improvements to treatment time and dose accuracy. Further long-term survival and intensity modulation studies are warranted, including direct comparisons of both dose modulation and treatment efficiency.  相似文献   
20.
The Impella 5.0, a percutaneously inserted left ventricular assist device, has been used to support patients who have severe heart failure or who are undergoing high-risk percutaneous coronary intervention. We report our surgical placement of the Impella 5.0, through a graft sewn to the aorta, to unload the left ventricle of a 59-year-old man who was undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy shock. The patient underwent successful placement of a long-term left ventricular assist device before his discharge from the hospital. The versatility of the Impella 5.0 is exemplified in this patient who was successfully bridged to long-term support.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号